| 英文名称 | 中文名称 | CAS | MF |
|
DSR-141562
|
3-甲基-7-(四氢-2H-吡喃-4-基)-2-((反式-4-(三氟甲基)环己基)甲氧基)咪唑并[5,1-F][1,2,4]三嗪-4(3H)-酮
|
2007975-22-4
|
C19H25F3N4O3
|
|
((1R,8S,9S)-BICYCLO[6.1.0]NON-4-YN-9-YL)METHYL 2-AMINOETHYLCARBAMATE
|
(1R,8S,9S)-二环[6.1.0]壬-4-炔-9-基甲基(2-氨基乙基)氨基甲酸酯
|
2008714-39-2
|
C13H20N2O2
|
|
Trans-Benzyl (4-Hydroxypyrrolidin-3-Yl)Carbamate Hydrochloride(WX601085)
|
苯甲基 ((3R,4R)-4-羟基吡咯烷-3-基)氨基甲酯盐酸
|
2008714-47-2
|
C12H17ClN2O3
|
|
Sitafloxacin Impurity 12
|
西他沙星杂质12
|
2008714-64-3
|
C10H14FNO3S
|
|
RockPhos Pd G3
|
RockPhos PD G3
|
2009020-38-4
|
C44H63NO4PPdS-
|
|
Octanedioic acid, 1-?[4-?(methoxycarbonyl)?phenyl] ester
|
2009023-78-1
|
2009023-78-1
|
C16H20O6
|
|
Benzaldehyde, 4,4'-[[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]imino]bis-
|
4,4'-((4-(4,4,5,5-四甲基-1,3,2-二氧杂硼杂环戊烷-2-基)苯基)氮杂二基)二苯甲醛
|
2009169-65-5
|
C26H26BNO4
|
|
GNE-6640
|
化合物USP7-IN-8
|
2009273-60-1
|
C21H21N3O2
|
|
GNE-6640
|
CS-2824
|
2009273-67-8
|
C20H18N4O
|
|
GEN6776
|
GEN6776
|
2009273-71-4
|
C20H20N4O2
|
|
Benzonitrile, 4-[1,2,4]triazolo[1,5-a]pyridin-5-yl-
|
化合物PHD-1-IN-1
|
2009343-14-8
|
C13 H8 N4
|
|
[1,2,4]Triazolo[1,5-a]pyridine-5-boronic Acid Pinacol Ester
|
[1,2,4]三唑并[1,5-A]吡啶-5-硼酸频哪醇酯
|
2009345-74-6
|
C12H16BN3O2
|
|
5,7-dichloro-[1,2,4]triazolo[1,5-a]pyridine
|
5,7-二氯-[1,2,4]三唑并[1,5-A]吡啶
|
2009345-75-7
|
C6H3Cl2N3
|
|
6-METHYL-5-(TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDINE-2-CARBONITRILE
|
6-甲基-5-(四甲基-1,3,2-二氧杂硼烷-2-基)吡啶-2-甲腈
|
2009346-11-4
|
C13H17BN2O2
|
|
4-Methyl-6-cyano
pyridine-3-boronic acid pinacol ester
|
4-甲基-5-(四甲基-1,3,2-二氧杂硼环戊烷-2-基)吡啶-2-甲腈
|
2009346-30-7
|
C13H17BN2O2
|
|
BIS-TRITYL-PEG13
|
|
2010151-26-3
|
C62H78O13
|
|
E3 ligase Ligand-Linker Conjugates 13
|
2010159-45-0
|
2010159-45-0
|
C28H39N7O6S
|
|
MZP-54
|
MZP-54
|
2010159-47-2
|
C55H66ClN7O9S
|
|
MZP-55
|
MZP-55
|
2010159-48-3
|
C57H70ClN7O10S
|
|
E3 ligase Ligand-Linker Conjugates 5 Free Base
|
E3 ligase Ligand-Linker Conjugates 5 Free Base
|
2010159-56-3
|
C30H45N5O7S
|
|
E3 ligase Ligand-Linker Conjugates 7 Free Base
|
E3 ligase Ligand-Linker Conjugates 7 Free Base
|
2010159-57-4
|
C32H49N5O8S
|
|
E3 ligase Ligand-Linker Conjugates 6 Free Base
|
2010159-60-9
|
2010159-60-9
|
C28H41N5O6S
|
|
Garcimultiflorone J
|
Garcimultiflorone J
|
2010216-41-6
|
C38H48O6
|
|
4-{[(tert-butoxy)carbonyl]amino}-2-oxabicyclo[2.2.2]octane-1-carboxylic acid
|
4-((叔丁氧基羰基)氨基)-2-氧杂二环[2.2.2]辛烷-1-羧酸
|
2010218-26-3
|
C13H21NO5
|
|
Argatroban Impurity 12 DiHCl
|
Argatroban Impurity 12 DiHCl
|
2010950-58-8
|
C13H25N5O3
|
|
4-Fluoro-2-nitrophenyl methanesulfonate
|
4-Fluoro-2-nitrophenyl methanesulfonate
|
2010955-38-9
|
C7H6FNO5S
|
|
6-Bromo-2,3-difluoro-4-hydroxybenzaldehyde
|
6-Bromo-2,3-difluoro-4-hydroxybenzaldehyde
|
2010955-48-1
|
C7H3BrF2O2
|
|
Acetamide, 2-[4-[(1-methylethyl)amino]butoxy]-N-(methylsulfonyl)-
|
Acetamide, 2-[4-[(1-methylethyl)amino]butoxy]-N-(methylsulfonyl)-
|
2010956-45-1
|
C10H22N2O4S
|
|
5-Methylpyrimidine-4,6-dicarboxylic acid
|
5-Methylpyrimidine-4,6-dicarboxylic acid
|
2010958-16-2
|
C7H6N2O4
|
|
(R)-4-Isopropyl-2-(5-(trifluoromethyl)pyridin-2-yl)-4,5-dihydrooxazole
|
(R)-4-Isopropyl-2-(5-(trifluoromethyl)pyridin-2-yl)-4,5-dihydrooxazole
|
2010973-00-7
|
C12H13F3N2O
|
|
6,10-Dibenzyl-N,N'-dimethyl-N,N,N',N'-tetrakis(4-methylbenzyl)-1,4-dioxaspiro[4.5]decane-(2R,3R)-diylbis(methylammonium) Bis(tetrafluoroborate) [=(R,R)-TaDiAS-2nd]
|
6,10-二苄基-N,N'-二甲基-N,N,N',N'-四(4-甲基苄基)-1,4-二氧杂螺[4.5]癸烷-(2R,3R)-二醇双(甲铵)四氟硼酸盐[=(R,R)-TADIAS-2ND]
|
2010983-27-2
|
C58H70BF4N2O2+
|
|
6,6',6'',6'''-(Pyrene-1,3,6,8-tetrayl)tetrakis(2-naphthoic acid)
|
6,6',6'',6'''-(芘-1,3,6,8-四甲苯基)四(2-萘甲酸)
|
2010983-66-9
|
C60H34O8
|
|
L-Prolinamide, glycyl-3-methyl-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-, (4R)-
|
(2S,4R)-1-((S)-2-(2-氨基乙酰胺基)-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺
|
2010986-20-4
|
C24H33N5O4S
|
|
2α-Acetoxy-14,15-cyclopimara-7β,16-diol
|
2α-Acetoxy-14,15-cyclopimara-7β,16-diol
|
2011034-27-6
|
C22H36O4
|
|
tert-Butyl 8-iodooctylcarbamate
|
(8-碘辛基)氨基甲酸叔丁酯
|
2011713-75-8
|
C13H26INO2
|
|
C18 Ceramide-d3 (d18:1/18:0-d3)
|
C18神经酰胺-d3(d18:1/18:0-d3)
|
2011762-82-4
|
C36H71NO3
|
|
N-[(1S)-1-[2-(9-anthracenyl)phenyl]-2-(diphenylphosphino)ethyl]-3,5-bis(trifluoromethyl)-Benzamide
|
(S)-N-(1-(2-(蒽-9-基)苯基)-2-(二苯基膦基)乙基)-3,5-二(三氟甲基)苯甲酰胺
|
2011787-22-5
|
C43H30F6NOP
|
|
2,5-Dioxopyrrolidin-1-yl 3-(3-(but-3-yn-1-yl)-3H-diazirin-3-yl)propanoate
|
2,5-二氧代吡咯烷-1-基3-(3-(丁-3-炔-1-基)-3H-二氮杂环丁-3-基)丙酸酯
|
2012552-32-6
|
C12H13N3O4
|
|
Bulevirtide
|
布尔韦肽
|
2012558-47-1
|
|
|
EC-359
|
化合物 T11146
|
2012591-09-0
|
C36H38F2O2
|
|
PRMWGUBFXWROHD-MYWHSQMISA-N
|
吡仑帕-D5
|
2012598-62-6
|
C23H15N3O
|
|
Chlorhexidine-d8 HCl
|
CHLORHEXIDINE-D8 HCL
|
2012598-75-1
|
C22H31Cl3N10
|
|
WNK463
|
N-(叔丁基)-1-(1-(5-(5-(三氟甲基)-1,3,4-恶二唑-2-基)吡啶-2-基)哌啶-4-基)-1H-咪唑-5-甲酰胺
|
2012607-27-9
|
C21H24F3N7O2
|
|
tert-butyl 1-(aminomethyl)cyclobutylmethylcarbamate
|
N-[1-(氨基甲基)环丁基]-N-甲基-氨基甲酸叔丁酯
|
2012991-41-0
|
C11H22N2O2
|
|
3-BROMO-6-METHYL-PYRIDINE-2,5-DIAMINE
|
|
2013095-37-7
|
C6H8BrN3
|
|
Ethanone, 1-(3,5-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)-
|
伏立康唑杂质68
|
2013304-99-7
|
C10H7F2N3O
|
|
1H-Pyrazole-1-acetic acid, 4-bromo-3,5-dimethyl-, 1,1-dimethylethyl ester
|
1H-吡唑-1-乙酸,4-溴-3,5-二甲基-,1,1-二甲基乙基酯
|
2013373-96-9
|
C11H17BrN2O2
|
|
1αH,5αH-guaia-6-ene-4β,10β-diol
|
1αH,5αH-Guaia-6-ene-4β,10β-diol #天然产物 HY-N5081
|
2013537-81-8
|
C15H26O2
|
|
6-bromo-4-iodoisoquinoline
|
6-溴-4-碘异喹啉
|
2013582-46-0
|
C9H5BrIN
|
|
4-bromoisoquinolin-6-amine
|
4-溴异喹啉-6-胺
|
2013582-86-8
|
C9H7BrN2
|
|
6-Methyl-2-[4-(methylsulfanyl)phenyl]-1,3,6,2-dioxazaborocane-4,8-dione
|
4-甲硫基苯硼酸甲基亚氨基二乙酸酯
|
2014379-39-4
|
C12H14BNO4S
|
|
Nangibotide
|
NANGIBOTIDE
|
2014384-91-7
|
C54H82N14O22S2
|
|
(2S)-3-cyclooctyl-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoic acid
|
|
2015188-99-3
|
C26H31NO4
|
|
(2R)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(3-fluoro-4-methoxyphenyl)propanoic acid
|
|
2015211-62-6
|
C25H22FNO5
|
|
Regadenoson Impurity 10
|
瑞加德松杂质10
|
2015222-31-6
|
C15H18N8O5
|
|
(2S,3R,4S,5R)-2-(6-Amino-2-chloro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
|
2-氯腺嘌呤核苷Α异构体碱
|
2015222-35-0
|
C10H12ClN5O4
|
|
(S)-2-Boc-amino-3-quinolin-4-yl-propionic acid
|
(S)-2-((叔丁氧基羰基)氨基)-3-(喹啉-4-基)丙酸
|
2015385-62-1
|
C17H20N2O4
|
|
N-Fmoc-3,5-dimethoxy-D-phenylalanine
|
N-Fmoc-3,5-dimethoxy-D-phenylalanine
|
2015414-19-2
|
C26H25NO6
|
|
tert-Butyl 2-(2-Methyl-1-pyrrolidinyl)acetate
|
2-(2-甲基-1-吡咯烷基)乙酸叔丁酯
|
2015655-98-6
|
C11H21NO2
|
|
2-(2-((5-bromo-4-(2-ethylhexyl)thiophen-2-yl)methylene)-3-oxo-2,3-dihydro-1H-inden-1-ylidene)malononitrile
|
PM140
|
2016036-48-7
|
C25H23BrN2OS
|
|
Fmoc-D-aMeSer(allyl)-OH
|
|
2016044-64-5
|
C22H23NO5
|
|
3-Cyano-4-(trifluoromethyl)phenylboronic Acid
|
(3-氰基-4-(三氟甲基)苯基)硼酸
|
2016766-76-8
|
C8H5BF3NO2
|
|
EC330
|
LIF抑制剂(EC330)
|
2016795-77-8
|
C30H32F2O2
|
|
AZ13705339
|
化合物 T26704
|
2016806-57-6
|
C33H36FN7O3S
|
|
1H-Imidazole-2-carboxylic acid, 1-(1-methylethyl)-, ethyl ester
|
1-异丙基-1H-咪唑-2-羧酸乙酯
|
2017188-77-9
|
C9H14N2O2
|
|
Potassium [4-(benzylamino-1-carbonyl)phenyl]trifluoroborate
|
[4-(苄氨基-1-羰基苯基]三氟硼酸钾
|
2017555-07-4
|
C14H12BF3KNO
|
|
Potassium [4-(furfurylamino-1-carbonyl)-phenyl]trifluoroborate
|
Potassium [4-(furfurylamino-1-carbonyl)-phenyl]trifluoroborate
|
2017555-09-6
|
C12H10BF3KNO2
|
|
BMT-145027
|
2018282-44-3
|
2018282-44-3
|
C23H14ClF3N4
|
|
4-tert-butyl 9-methyl 7-bromo-2,3-dihydrobenzo[f][1,4]oxazepine-4,9(5H)-dicarboxylate(WX142320)
|
4-tert-butyl 9-methyl 7-bromo-2,3-dihydrobenzo[f][1,4]oxazepine-4,9(5H)-dicarboxylate(WX142320)
|
2018300-50-8
|
C16H20BrNO5
|
|
TPOP146
|
化合物 TPOP146
|
2018300-62-2
|
C27H35N3O5
|
|
6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyrimidine
|
6-(4,4,5,5-四甲基-1,3,2-二噁硼烷-2-基)咪唑并[1,2-A]嘧啶
|
2018362-18-8
|
C12H16BN3O2
|
|
(3R,4S)-1-AzetidinecarboxylicAcid-3-(2-Ethoxyethoxy)-4-Phenyl-2-Phenyl-AzetidioneCasNo.
|
|
201856-567-7
|
|
|
4-(3-bromo-4-fluorophenyl)-3-(4-nitro-1,2,5-oxadiazol-3-yl)-1,2,4-oxadiazol-5(4H)-one
|
3-(4-硝基-1,2,5-噁二唑-3-基)-4-(3-溴-4-氟苯基)-1,2,4-噁二唑-5(4H)-酮
|
2019140-71-5
|
C10H3BrFN5O5
|
|
DPAc-MPM
|
2-甲基-4,6-双[4-(9,9-二苯基-9,10-二氢吖啶)苯基]嘧啶
|
2019165-20-7
|
C67H48N4
|
|
DPAc-PPM
|
2-苯基-4,6-双[4-(9,9-二苯基-9,10-二氢吖啶)苯基]嘧啶
|
2019165-21-8
|
C72H50N4
|
|
Pegcetacoplan
|
PEGCETACOPLAN(APL-2)
|
2019171-69-6
|
|
|
(2R,3R)-N-((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)-3-Methoxy-2-Methyl-3-((S)-pyrrolidin-2-yl)propanaMide (hydrochloride)
|
(2R,3R)-N - ((1S,2R)-1-羟基-1-苯基丙-2-基)-3-甲氧基-2-甲基-3
|
2019182-02-4
|
C18H29ClN2O3
|
|
1-(Cyclopropylmethyl)pyrazole-5-boronic acid pinacol ester
|
1-(Cyclopropylmethyl)pyrazole-5-boronic acid pinacol ester
|
2019997-41-0
|
C13H21BN2O2
|
|
1-ethyl-3-methyl-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
|
1-ethyl-3-methyl-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
|
2019997-43-2
|
C12H21BN2O2
|
|
CDK12 inhibitor E9 S-isomer
|
CDK12 inhibitor E9 S-isomer
|
2020052-55-3
|
C24H30N6O2
|
|
1-(3,3-difluorocyclobutyl)piperazine(WXC08972)
|
1-(3,3-二氟环丁基)哌嗪
|
2020056-51-1
|
C8H14F2N2
|
|
Isoxazole, 4-(tributylstannyl)-
|
4-(三丁基甲锡烷基)-异恶唑
|
2020067-63-2
|
C15H29NOSn
|
|
4-(3-fluoro-4-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)-1,2,3,6-tetrahydropyridine hydrochloride
|
4-(3-氟-4-(1-甲基-1H-1,2,4-三唑-3-基)苯基)-1,2,3,6-四氢吡啶 盐酸盐
|
2020069-42-3
|
C14H16ClFN4
|
|
2-(4-chloro-3-cyclopropylphenyl)-4,4,5,5-tetraMethyl-1,3,2-dioxaborolane
|
|
2020084-22-2
|
C15H20BClO2
|
|
2H-Imidazo[4,5-c]quinolin-2-one, 8-(1,3-dimethyl-1H-pyrazol-4-yl)-1-(3-fluoro-5-methoxy-4-pyridinyl)-1,3-dihydro-7-methoxy-3-methyl-
|
|
2020089-41-0
|
C23H21FN6O3
|
|
6-BROMO-4-CHLORO-7-METHOXY-3-NITROQUINOLINE
|
6-溴-4-氯-7-甲氧基-3-硝基喹啉
|
2020090-85-9
|
C10H6BrClN2O3
|
|
Benzenemethanol, 2,6-difluoro-4-iodo-
|
(2,6-二氟-4-碘苯基)甲醇
|
2020326-12-7
|
C7H5F2IO
|
|
S312
|
S312
|
2020336-80-3
|
C17H12ClN3O2S
|
|
MMAE-SMCC
|
MMAE-SMCC
|
2021179-11-1
|
C58H89N7O14S
|
|
(S)-3-(tert-butyl)-4-(4',6'-dimethoxy-[1,1':3',1''-terphenyl]-5'-yl)-2,3-dihydrobenzo[d][1,3]oxaphosphole
|
(S)-3-(TERT-BUTYL)-4-(4',6'-DIMETHOXY-[1,1':3',1''-TERPHENYL]-5'-YL)-2,3-DIHYDROBENZO[D][1,3]OXAPHOSPHOLE
|
2021201-99-8
|
C31H31O3P
|
|
(S)-3-(tert-butyl)-4-(2,6-dimethoxy-3,5-dimethylphenyl)-2,3-dihydrobenzo[d][1,3]oxaphosphole
|
(S)-3-(叔丁基)-4-(2,6-二甲氧基-3,5-二甲基苯基)-2,3-二氢苯并[D][1,3]氧杂磷杂环戊烯
|
2021202-03-7
|
C21H27O3P
|
|
5-Chloro-3-nitro-1H-pyrazolo[4,3-b]pyridine
|
5-Chloro-3-nitro-1H-pyrazolo[4,3-b]pyridine
|
2021203-20-1
|
C6H3ClN4O2
|
|
Sildenafil Impurity 25
|
西地那非杂质25
|
2021224-02-0
|
C9H10O6S
|
|
7-chloroimidazo[1,5-a]pyridine-5-carbaldehyde
|
7-chloroimidazo[1,5-a]pyridine-5-carbaldehyde
|
2021235-95-8
|
C8H5ClN2O
|
|
Ethyl 6-Chloroimidazo[1,5-a]pyridine-5-carboxylate
|
6-氯咪唑并[1,5-A]吡啶-5-甲酸乙酯
|
2021236-22-4
|
C10H9ClN2O2
|
|
Vilanterol Impurity 22(Vilanterol-d4 Triphenylacetate)
|
维兰特罗杂质22
|
2021249-10-3
|
C44H49Cl2NO7
|
|
Erlotinib Impurity 23
|
厄洛替尼杂质23
|
2021249-11-4
|
C23H18F6N6O
|
|
PHENYLEPHRINE GLUCURONIDE
|
苯福林葡糖苷酸
|
2021255-73-0
|
C15H21NO8
|
|
QPhos Pd G3
|
QPHOS PD G3
|
2021255-91-2
|
C61H56FeNO3PPdS
|
|
4'-(pyridin-4-yl)-[1,1'-biphenyl]-3,5-dicarboxylic acid
|
1-吡啶基-4-(3',5'-间苯二甲酸基)-苯
|
2022152-71-0
|
C19H13NO4
|